Biogaran takes part in a vast screening operation for people over 60 in Guinea

Biogaran, France’s leading generic pharmaceutical company, has demonstrated its commitment to patient care in Guinea by taking an active part in the Caravane Santé 3ème Âge operation. This initiative by the Orange Guinea Foundation, in collaboration with Santé en Entreprise, enabled a wide-ranging campaign to raise awareness of cardio-metabolic pathologies among people over 60, particularly in the fight against diabetes and high blood pressure.  

This large-scale operation – carried out from May 2 to June 22, 2023 in 8 regions of Guinea – aimed to welcome 13,000 patients, mostly aged over 60, to raise their awareness of the risks posed by cardio-metabolic pathologies to their health. Screenings were also carried out with a view to follow-up and medical treatment. The results at the end of the two months were a major success in terms of the number of patients sensitized, with a total of 13,054 people welcomed for 12,709 patients screened.  

It should be noted that this operation follows on from the 2022 edition, carried out on a smaller sample and in just 4 regions. The previous edition had already welcomed 2,163 patients, of whom 2,009 were screened and 1,775 referred to a doctor for medical treatment. The results of the Caravane Santé 3ème Âge 2023 are therefore up sharply, enabling more than twice as many patients to be cared for.  

This initiative was made possible by the coordinated action of the Orange Guinea Foundation and Santé en Entreprise. Complementing each other, these two entities have acted on several levers to obtain approvals, organize and ensure rigorous follow-up of screened patients. As for Biogaran, the laboratory has taken part in the training of over 250 healthcare professionals – general practitioners, diabetologists, cardiologists, nurses, counsellors, pharmacists and prevention workers – and donated over 10,000 boxes of medicines to enable the medical management of screened patients.